A systematic review and meta-analysis of the impact of collaborative practice between community pharmacist and general practitioner on asthma management

References

• Global Asthma Network. The Global Asthma Report 2018. The Global Asthma Network: Vol. 5 Auckland, New Zealand; 2018 ISBN: 978-0-473-29125-9\r978-0-473-29126-6 (Electronic).
   Google Scholar
• Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. The Global Initiative for Asthma: Fontana, WI; 2018.
   Google Scholar
• Burney P, Jarvis D, Perez-Padilla R. The global burden of chronic respiratory disease in adults. Int J Tuberc Lung Dis. 2015;19(1):10–20. doi:10.5588/ijtld.14.044625519785
   PubMed Web of Science ®Google Scholar
• WHO. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases. World Health Organization: Geneva; 2007 ISBN 978 92 4 156346 8.
   Google Scholar
• Garcia-Cardenas V, Sabater-Hernandez D, Kenny P, Martinez-Martinez F, Faus MJ, Benrimoj SI. Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respir Med. 2013;107(9):1346–1355. doi:10.1016/j.rmed.2013.05.01423810267
   PubMed Web of Science ®Google Scholar
• Bradley CL, Luder HR, Beck AF, et al. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration. J Am Pharm Assoc. 2016;56(4):455–460. doi:10.1016/j.japh.2016.03.007
   Google Scholar
• Barton C, Proudfoot J, Amoroso C, et al. Management of asthma in Australian general practice: care is still not in line with clinical practice guidelines. Prim Care Respir J. 2008;18(2):100–105. doi:10.3132/pcrj.2008.00059
   Google Scholar
• Wiener-Ogilvie S, Pinnock H, Huby G, Sheikh A, Partridge MR, Gillies J. Do practices comply with key recommendations of the British asthma guideline? If not, why not? Prim Care Respir J. 2007;16(6):369–377. doi:10.3132/pcrj.2007.0007418026674
   PubMedGoogle Scholar
• Watkins K, Bourdin A, Trevenen M, et al. Opportunities to develop the professional role of community pharmacists in the care of patients with asthma : a cross-sectional study. NPJ Primary Care Respir Med. 2016;26. doi:10.1038/npjpcrm.2016.82
   Web of Science ®Google Scholar
• Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother. 2009;43(1):85–97. doi:10.1345/aph.1K61219109213
   PubMed Web of Science ®Google Scholar
• Felix J, Ferreira D, Afonso-Silva M, et al. Social and economic value of portuguese community pharmacies in health care. BMC Health Serv Res. 2017;17:1. doi:10.1186/s12913-017-2525-428049468
   PubMed Web of Science ®Google Scholar
• Alotaibi HS, Shivanandappa TB, Nagarethinam S. Contribution of community pharmacists in educating the asthma patients. Saudi Pharm J. 2016;24(6):685–688. doi:10.1016/j.jsps.2015.06.00227829811
   PubMed Web of Science ®Google Scholar
• Carter BL. Primary care physician-pharmacist collaborative care model: strategies for implementation. Pharmacotherapy. 2016;36(4):363–373. doi:10.1002/phar.173226931738
   PubMed Web of Science ®Google Scholar
• Hisashige A. The effectiveness and efficiency of disease management programs for patients with chronic diseases. Glob J Health Sci. 2013;5(2):27–48. doi:10.5539/gjhs.v5n2p27
   Google Scholar
• Gums TH, Carter BL, Milavetz G, et al. Physician-pharmacist collaborative management of asthma in primary care. Pharmacotherapy. 2014;34(10):1033–1042. doi:10.1002/phar.146825142870
   PubMed Web of Science ®Google Scholar
• Berry TM, Prosser TR, Wilson K, Castro M. Asthma friendly pharmacies: A model to improve communication and collaboration among pharmacists, patients, and healthcare providers. J Urban Heal. 2011;88(SUPPL. 1):113–125. doi:10.1007/s11524-010-9514-9
   Web of Science ®Google Scholar
• McBane SE, Dopp AL, Abe A, et al. Collaborative drug therapy management and comprehensive medication management - 2015. Pharmacotherapy. 2015;35(4):e39–e50. doi:10.1002/phar.156325884536
   PubMed Web of Science ®Google Scholar
• Yong YV, Shafie AA. How much does management of an asthma-related event cost in a malaysian suburban hospital? Value Heal Reg Issues. 2018;15:6–11. doi:10.1016/j.vhri.2017.05.001
   Google Scholar
• Crespo-Gonzalez C, Fernandez-Llimos F, Rotta I, Correr CJ, Benrimoj SI, Garcia-Cardenas V. Journal of the American pharmacists association characterization of pharmacists ’ interventions in asthma management : A systematic review. J Am Pharm Assoc. 2018;1–10. doi:10.1016/j.japh.2017.12.009
   Google Scholar
• Portlock BJ, Holden M, Patel S. Original papers A community pharmacy asthma MUR project in hampshire and the isle of wight. Pharm J. 2009;282(January):109–112.
   Google Scholar
• Bollmeier SG, Prosser TR. Community pharmacy-based asthma services : current perspectives and future directions. Integr Pharm Res Pract. 2014;3:49–70. doi:10.2147/IPRP.S47331
   Google Scholar
• Garcia-Cardenas V, Armour C, Benrimoj SI, Martinez-Martinez F, Rotta I, Fernandez-Llimos F. Pharmacists’ interventions on clinical asthma outcomes: A systematic review. Eur Respir J. 2016;47(4):1134–1143. doi:10.1183/13993003.01497-201526677937
   PubMed Web of Science ®Google Scholar
• Adunlin G, Mahdavian S. The effectiveness of pharmacist interventions on asthma management: a systematic review. J Asthma Allergy Educ. 2012;3(6):264–273. doi:10.1177/2150129712464775
   Google Scholar
• Mes MA, Katzer CB, Chan AHY, Wileman V, Taylor SJC, Horne R. Pharmacists and medication adherence in asthma: a systematic review and meta-analysis. Eur Respir J. 2018;52(2):1800485. doi:10.1183/13993003.00485-201829976652
   PubMed Web of Science ®Google Scholar
• Brown D, Portlock J, Rutter P. Review of services provided by pharmacies that promote healthy living. Int J Clin Pharm. 2012;34(3):399–409. doi:10.1007/s11096-012-9634-222527479
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. doi:10.1371/journal.pmed.100010019621070
   PubMed Web of Science ®Google Scholar
• Effective Practice and Organisation of Care (EPOC). Suggested risk of bias criteria for EPOC reviews; 2016 Available from: http://epoc.cochrane.org/resources/epoc-resources-review-authors. Accessed 1125, 2018.
   Google Scholar
• Khan KS, Kunz R, Kleijnen J, Antes G. Systematic Reviews to Support Evidence-Based Medicine. 2nd ed. London: Hodder & Stoughton Ltd; 2011.
   Google Scholar
• Verhagen AP, Ferreira ML. Forest plots. J Physiother. 2014;60(3):170–173. doi:10.1016/j.jphys.2014.06.02125084633
   PubMedGoogle Scholar
• Fletcher J. What is heterogeneity and is it important? Br Med J. 2007;334(7584):91–94. doi:10.1136/bmj.39038.614317.AE17218715
   PubMed Web of Science ®Google Scholar
• Ried K. Interpreting and understanding meta-analysis graphs. A practical guide. Aust Fam Physician. 2006;35(8):1–24.
   Google Scholar
• Israel H, Richter RR. A guide to understanding meta-analysis. J Orthop Sport Phys Ther. 2011;41(7):496–504. doi:10.2519/jospt.2011.3333
   PubMed Web of Science ®Google Scholar
• Stephenson J. Explaining the forest plot in meta-analyses. J Wound Care. 2017;26(11):2017–2018. doi:10.12968/jowc.2017.26.11.611
   Web of Science ®Google Scholar
• Sedgwick P. How to read a forest plot in a meta-analysis. BMJ. 2012;351(December):h4028. doi:10.1136/bmj.h4028
   Web of Science ®Google Scholar
• Sedgwick P. Meta-analyses: heterogeneity and subgroup analysis. BMJ. 2013;346(7914):9–11. doi:10.1136/bmj.f4040
   Web of Science ®Google Scholar
• Zlowodzki M, Poolman RW, Kerkhoffs GM, Tornetta P, Bhandari M. How to interpret a meta-analysis and judge its value as a guide for clinical practice. Acta Orthop. 2007;78(5):598–609. doi:10.1080/1745367071001428417966018
   PubMed Web of Science ®Google Scholar
• Hak T, van Rhee H, Suurmond R. How to interpret results of meta- analysis. (Version 1.3). 1st ed. Rotterdam, The Netherlands: Erasmus Rotterdam Institute of Management; 2016:1–21. doi:10.2139/ssrn.3241367
   Google Scholar
• Chong-Ho Yu PD. Meta-Analysis and Effect Size. 2010:1–24. Available from: http://www.creative-wisdom.com/teaching/WBI/es.shtml. Creative Wisdom.
   Google Scholar
• Faraone SV. Interpreting estimates of treatment effects: implications for managed care. P T J Formul Manag. 2008;33(12):700–711. doi:10.1093/jicru/ndm032
   PubMedGoogle Scholar
• Durlak JA. How to select, calculate, and interpret effect sizes. J Pediatr Psychol. 2009;34(9):917–928. doi:10.1093/jpepsy/jsp00419223279
   PubMed Web of Science ®Google Scholar
• Fritz CO, Morris PE, Richler JJ. Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen. 2012;141(1):2–18. doi:10.1037/a002433821823805
   PubMed Web of Science ®Google Scholar
• Charrois T, Newman S, Sin D, Senthilselvan A, Tsuyuki RT. Improving asthma symptom control in rural communities: the design of the better respiratory education and asthma treatment in hinton and edson study. Can Pharm J. 2006;139(4):44–50. doi:10.1016/j.cct.2004.07.004
   Google Scholar
• Manfrin A, Tinelli M, Thomas T, Krska J. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Serv Res. 2017;17(1):300. doi:10.1186/s12913-017-2245-928438152
   PubMed Web of Science ®Google Scholar
• Crowder T. An Evaluation of Community Pharmacists Applying the Patient Centered Care Approach to Ambulatory Oregon Health Plan Asthmatics in a Managed Care Setting. 2000. Oregon States University.
   Google Scholar
• Bunting BA, Cranor CW. The asheville project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46(2):133–147. doi:10.1331/154434506776180658
   Google Scholar
• Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother. 2004;38(11):1954–1960. doi:10.1345/aph.1E04515479780
   PubMed Web of Science ®Google Scholar
• Armour C, Reddel HK, LeMay KS, et al. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma. 2013;50(3):302–309. doi:10.3109/02770903.2012.75446323270495
   PubMed Web of Science ®Google Scholar
• Bereznicki B, Peterson G, Jackson S, Haydn Walters E, Deboos I, Hintz P. Perceived feasibility of a community pharmacy-based asthma intervention: A qualitative follow-up study. J Clin Pharm Ther. 2011;36(3):348–355. doi:10.1111/j.1365-2710.2010.01187.x21545614
   PubMed Web of Science ®Google Scholar
• Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007;62(6):496–502. doi:10.1136/thx.2006.06470917251316
   PubMed Web of Science ®Google Scholar
• Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy. 2001;21(10):1196–1203. doi:10.1592/phco.21.15.1196.3389411601666
   PubMed Web of Science ®Google Scholar
• Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J. 2008;31(4):790–799. doi:10.1183/09031936.0011200718094011
   PubMed Web of Science ®Google Scholar
• Mangiapane S, Schulz M, Mühlig S, Ihle P, Schubert I, Waldmann HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother. 2005;39(11):1817–1822. doi:10.1345/aph.1G18016219893
   PubMed Web of Science ®Google Scholar
• McLean W, Gillis J, Waller R, The BC community pharmacy asthma study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2003;10(4):195–202. doi:10.1155/2003/73604212851665
   PubMedGoogle Scholar
• Amirthalingam ARS. An evaluation of a community pharmacy based, pharmacist-led intervention package targeted to the patients’ adherence status, to achieve and maintain target blood pressure (BP) control by optimising antihypertensive medicine adherence; 2017 Available from: http://etheses.bham.ac.uk/7834/. Accessed 1125, 2018.
   Google Scholar
• Bereznicki BJ, Peterson GM, Jackson SL, Walters H, Fitzmaurice K, Gee P. Pharmacist-initiated general practitioner referral of patients with suboptimal asthma management. Pharm World Sci. 2008;30(6):869–875. doi:10.1007/s11096-008-9242-318679820
   PubMedGoogle Scholar
• Schulz M, Verheyen F, Muhlig S, et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol. 2001;41(6):668–676. doi:10.1177/0091270012201043811402636
   PubMed Web of Science ®Google Scholar
• Barbanel D, Eldridge S, Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial. Thorax. 2003;58(10):851–854. doi:10.1136/thorax.58.10.85114514935
   PubMed Web of Science ®Google Scholar
• Bereznicki BJ, Peterson G, Jackson S, et al. Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management. J Clin Pharm Ther. 2013;38(3):212–218. doi:10.1111/jcpt.1201723437933
   PubMed Web of Science ®Google Scholar
• Narhi U, Airaksinen M, Tanskanen P, Erlund H. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. J Clin Pharm Ther. 2000;25(3):177–183. doi:10.1046/j.1365-2710.2000.00276.x10886462
   PubMed Web of Science ®Google Scholar
• Saini B, LeMay K, Emmerton L, et al. Asthma disease management-Australian pharmacists’ interventions improve patients’ asthma knowledge and this is sustained. Patient Educ Couns. 2011;83(3):295–302. doi:10.1016/j.pec.2011.05.00121621947
   PubMed Web of Science ®Google Scholar
• Grainger-Rousseau TJ, Mcelnay JC. Grainger-Rousseau,1997.pdf. J Appl Ther. 1997;1(1):145–161.
   Google Scholar
• Herborg H, Soendergaard B, Froekjaer B, et al. Improving drug therapy for patients with asthma–part 1: patient outcomes. J Am Pharm Assoc. 2001;41(4):539–550. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11486980
   Google Scholar
• Bereznicki BJ, Peterson GM, Jackson SL, Walters EH, Fitzmaurice KD, Gee PR. Data-mining of medication records to improve asthma management. Med J Aust. 2008;189(1):21–25.18601636
   PubMed Web of Science ®Google Scholar
• Bereznicki B, Peterson G, Jackson S, Walters EH, Gee P. The sustainability of a community pharmacy intervention to improve the quality use of asthma medication. J Clin Pharm Ther. 2011;36(2):144–151. doi:10.1111/j.1365-2710.2010.01165.x21366642
   PubMed Web of Science ®Google Scholar